نمایش پرونده ساده آیتم

dc.contributor.authorLeylabadlo, HE
dc.contributor.authorKafil, HS
dc.contributor.authorYousefi, M
dc.contributor.authorAghazadeh, M
dc.contributor.authorAsgharzadeh, M
dc.date.accessioned2018-08-26T05:37:14Z
dc.date.available2018-08-26T05:37:14Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/39807
dc.description.abstractIn recent years, in spite of medical advancement, tuberculosis (TB) remains a worldwide health problem. Although many laboratory methods have been developed to expedite the diagnosis of TB, delays in diagnosis remain a major problem in the clinical practice. Because of the slow growth rate of the causative agent Mycobacterium tuberculosis, isolation, identification, and drug susceptibility testing of this organism and other clinically important mycobacteria can take several weeks or longer. During the past several years, many methods have been developed for direct detection, species identification, and drug susceptibility testing of TB. A good understanding of the effectiveness and practical limitations of these methods is important to improve diagnosis. This review summarizes the currently-used advances in nonmolecular and molecular diagnostics.
dc.language.isoEnglish
dc.relation.ispartofTuberculosis and respiratory diseases
dc.titlePulmonary Tuberculosis Diagnosis: Where We Are?
dc.typearticle
dc.citation.volume79
dc.citation.issue3
dc.citation.spage134
dc.citation.epage42
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.4046/trd.2016.79.3.134


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم